Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MYCELA AS
AS
Active
Org 925541400
Jens Bjelkes Gate 47A, 0578 Oslo
Other manufacturing n.e.c. · NACE 3299
Est. 2020
0 employees
www.mycela.no
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2021
NOK 270K
+260% vs 2020
EBITDA margin
-23.3%
-209% vs 2020
Equity ratio
-15.0%
Financial strength
Net profit 2021
NOK -145K
-424% vs 2020
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
0%
2021
Key figures
Annual report 2021
Revenue
NOK 270K
+260%
EBITDA
NOK -63K
-209%
Net profit
NOK -145K
-424%
Total assets
NOK 493K
+430%
Equity
NOK -74K
-201%
Employees
0
—
Company information
Legal name
MYCELA AS
Org number
925541400
Legal form
Aksjeselskap
NACE code
3299 · Other manufacturing n.e.c.
Founded
9. oktober 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Mycelium (rotsystemet til sopp) og lavverdig organisk avfall blir utnyttet for å produsere et sirkulært og bærekraftig biomateriale.
Contact
Address
Jens Bjelkes Gate 47A, 0578 Oslo
Website
www.mycela.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other manufacturing n.e.c.
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
Income statement
NOK thousands
Item
2020
2021
Revenue
75
270
Staff expenses
−0
−2
EBITDA
58
−63
Depreciation & amort.
−0
−82
EBIT
58
−145
Net financials
0
−0
Profit before tax
58
−145
Tax
13
−0
Net profit
45
−145
Balance sheet
NOK thousands
Item
2020
2021
Total assets
93
493
Equity
73
−74
Long-term debt
0
400
Short-term debt
20
167
Total debt
20
567
Financial ratios
5-year trend
EBITDA margin
-23.3%
This company
15.8%
Market median
-247% vs market
2020
2021
Equity ratio
-15.0%
This company
38.2%
Market median
-139% vs market
2020
2021
Return on equity
-14542000.0%
This company
18.4%
Market median
-79032709% vs market
2020
2021
Net profit margin
-53.8%
This company
8.1%
Market median
-764% vs market
2020
2021
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
2020
2021
Debt / equity
7.66×
This company
0.62×
Market median
-1135% vs market
2020
2021
Annual reports & filings
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
RI
Reneè Isabel Bakkemo
Chief Executive Officer
Chief Executive Officer
2020
—
—
RI
Reneè Isabel Jung
Chief Executive Officer
Chief Executive Officer
2020
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
AD
Anne Dubrau
Chairman
2022
—
—
SE
Sondre Eng
Board of Directors
2022
—
—
CA
Christian Alexander Dubrau
Board of Directors
2022
—
—
MH
Maria Helena Aaslund
Board of Directors
2022
—
—
AG
Andrea Gamst
Board of Directors
2020
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MYCELA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Reneè Isabel Bakkemo
Chief Executive Officer
0 companies
Reneè Isabel Jung
Chief Executive Officer
0 companies
Anne Dubrau
Chairman
0 companies
Sondre Eng
Board of Directors
0 companies
Christian Alexander Dubrau
Board of Directors
0 companies
Maria Helena Aaslund
Board of Directors
0 companies
Andrea Gamst
Board of Directors
0 companies